Haematex Research Pty Ltd
Specialising in blood coagulation, Haematex Research is research oriented, investigating how to improve tests for diagnosis of bleeding and clotting disorders. Our particular interest is in prediction of thrombotic events such as DVT, strokes and cardiovasular events and their prevention with anticoagulants. We distribute haemostasis products from Hyphen Biomed (France) and research antibodies and kits from Bioporto (Denmark).We export reagents in powder form and licence our IP to major diagnostic producers overseas.
Number of employees: 3
Main business focus/
Listing by sector:
- Haematology & Anaemia
- Research Organisation
- Medical Devices
Extensive laboratory experience in test design, diagnosis and result interpretation in the field of blood coagulation, biomaterials and ELISA testing. Access to range of phospholipids, snake venoms and enzymes through partnerships. Long background in autoimmune disease and lupus inhibitor testing.
Locally-developed stable liquid APTT and dRVVT reagents for coagulation testing. Instrumentation for analysis of blood coagulation kinetics, ELISA development and protein purifications. Blood coagulation testing reagents in powdered form for bulk low cost delivery.
Linkages with Hyphen Biomed, France, Bioporto, Denmark, MediRox, Sweden, Vital Diagnostics and Sydney Skin and Vein Clinic.
Possibilities to undertake partnerships looking at effect of natural products, disease, diet or life style on blood coagulation and risk of thrombosis, stroke or myocardial infarction.
Looking for a small sized electronic platform for which we can develop reagents for "point of care" coagulation testing.
|Contact person||Dr Thomas Exner|
|17 King Rd|
|State||New South Wales|
|Phone||02 9482 2288|
|Fax||02 9482 2288|